Posaconazole Tablet, Delayed Release
Product Images NDC 72319-023

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Posaconazole (NDC 72319-023). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by I3 Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container (Container)

Each tablet contains 100 mg of Posaconazole. The usual dosage should be referred to the package insert. Posaconazole should be stored at a temperature between 20°C to 25°C (68°F to 77°F), with excursions permitted within a range of 15°C to 30°C (59°F to 86°F). These tablets are intended for delayed-release. It is important to note that Noxafil® Oral Suspension and Delayed-Release Tablets are not interchangeable due to differences in dosing between the two formulations. This product is manufactured by RxOnly 600 Tablets i3 Pharmaceuticals, LLC in Warminster, PA 18974. Rev.03/23 L02302.02-R0323.*

FDA Label Image

Structure.jpg (Structure.jpg)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.